Allianz Asset Management’s Immunomedics Inc IMMU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-1,153,818
| Closed | -$98.1M | – | 2009 |
|
|
2020
Q3 | $98.1M | Sell |
1,153,818
-377,248
| -25% | -$19.1M | 0.11% | 187 |
|
|
2020
Q2 | $54.3M | Buy |
1,531,066
+1,429,901
| +1,413% | +$41.8M | 0.06% | 322 |
|
|
2020
Q1 | $1.36M | Sell |
101,165
-10,908
| -10% | -$184K | ﹤0.01% | 1661 |
|
|
2019
Q4 | $2.37M | Sell |
112,073
-28,762
| -20% | -$507K | ﹤0.01% | 1792 |
|
|
2019
Q3 | $1.91M | Sell |
140,835
-246
| -0.2% | -$3.62K | ﹤0.01% | 1846 |
|
|
2019
Q2 | $1.96M | Sell |
141,081
-39,865
| -22% | -$600K | ﹤0.01% | 1893 |
|
|
2019
Q1 | $3.48M | Sell |
180,946
-134,112
| -43% | -$2.16M | ﹤0.01% | 1619 |
|
|
2018
Q4 | $4.51M | Buy |
315,058
+78,266
| +33% | +$1.55M | ﹤0.01% | 1452 |
|
|
2018
Q3 | $4.93M | Buy |
236,792
+211,671
| +843% | +$5.01M | ﹤0.01% | 1564 |
|
|
2018
Q2 | $595K | Sell |
25,121
-76,010
| -75% | -$1.53M | ﹤0.01% | 2352 |
|
|
2018
Q1 | $1.48M | Sell |
101,131
-16,449
| -14% | -$269K | ﹤0.01% | 2057 |
|
|
2017
Q4 | $1.9M | Sell |
117,580
-6,330
| -5% | -$74.7K | ﹤0.01% | 2034 |
|
|
2017
Q3 | $1.73M | Sell |
123,910
-73,128
| -37% | -$729K | ﹤0.01% | 2060 |
|
|
2017
Q2 | $1.74M | Sell |
197,038
-4,947
| -2% | -$34.7K | ﹤0.01% | 2032 |
|
|
2017
Q1 | $1.31M | Buy |
+201,985
| New | +$1.02M | ﹤0.01% | 2147 |
|
|
2014
Q3 | – | Sell |
-100,000
| Closed | -$365K | – | 2398 |
|
|
2014
Q2 | $365K | Hold |
100,000
| – | – | ﹤0.01% | 1661 |
|
|
2014
Q1 | $421K | Hold |
100,000
| – | – | ﹤0.01% | 1614 |
|
|
2013
Q4 | $460K | Hold |
100,000
| – | – | ﹤0.01% | 1561 |
|
|
2013
Q3 | $620K | Buy |
100,000
+30,000
| +43% | +$173K | ﹤0.01% | 1474 |
|
|
2013
Q2 | $381K | Buy |
+70,000
| New | +$230K | ﹤0.01% | 1528 |
|
Allianz Asset Management's IMMU Position: Q4 2020 in Review
Allianz Asset Management sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 1,153,818 shares — an estimated $98.1M sold.
Allianz Asset Management first reported a position in IMMU in Q2 2013 and held it in 20 quarters. The position peaked at $98.1M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.
- Allianz Asset Management reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
- Allianz Asset Management sold 1,153,818 Immunomedics Inc shares in Q4 2020, an estimated $98.1M.
- Allianz Asset Management first reported a position in Immunomedics Inc in Q2 2013 and held it in 20 quarters.
- Allianz Asset Management's Immunomedics Inc position peaked at $98.1M in Q3 2020.
- 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.
Based on Allianz Asset Management's 13F filing for Q4 2020, filed 16 Feb 2021.